VeriMomIst crataegus pinnatifida fruit extract in der Schwangerschaft sicher?
No harmonised CLP reproductive classification for Crataegus pinnatifida fruit extract (no ECHA Annex VI entry). No CIR or SCCS safety assessment flagging reproductive toxicity. PubMed literature on C. pinnatifida reports antioxidant/cardiovascular pharmacology but no consistent evidence of teratogenicity or human reproductive hazard from topical use. Typical topical plant extracts have low but measurable dermal exposure in cosmetics, so exposure scored as low (1). Sources consulted: ECHA Annex VI (no harmonised classification), PubMed (no reproductive hazard studies identified), PubChem/CosIng entries (ingredient identity and cosmetic use).
Related ingredients
Frequently asked questions
- Ist crataegus pinnatifida fruit extract in der Schwangerschaft sicher?
- No harmonised CLP reproductive classification for Crataegus pinnatifida fruit extract (no ECHA Annex VI entry). No CIR or SCCS safety assessment flagging reproductive toxicity. PubMed literature on C. pinnatifida reports antioxidant/cardiovascular pharmacology but no consistent evidence of teratogenicity or human reproductive hazard from topical use. Typical topical plant extracts have low but measurable dermal exposure in cosmetics, so exposure scored as low (1). Sources consulted: ECHA Annex VI (no harmonised classification), PubMed (no reproductive hazard studies identified), PubChem/CosIng entries (ingredient identity and cosmetic use).
- Ist crataegus pinnatifida fruit extract während des Stillens sicher?
- No evidence of reproductive or lactation-specific toxicity or transfer in humans for C. pinnatifida fruit extract in the referenced sources. Mechanistic data for placental or breast‑milk transfer are not available. Given low but measurable dermal exposure from cosmetics, exposure scored as low (1). Sources: PubMed (no breastfeeding transfer data), CosIng/PubChem (use and composition information).
- Ist crataegus pinnatifida fruit extract sicher für Babyhaut?
- No infant-specific safety signals or reproductive/dermal toxicity data identified. Mechanistic concerns not identified. Because infant skin has higher absorption (immature barrier and higher surface-area-to-weight), exposure is increased by +1 vs adult (adult e=1 → infant e=2). Sources: general dermal exposure principles, CosIng/PubChem for ingredient use, PubMed (no infant-specific hazard data).
- Wie bewertet VeriMom crataegus pinnatifida fruit extract?
- VeriMom bewertet crataegus pinnatifida fruit extract mit 93/100 (keine bekannten Risiken) basierend auf EU CosIng, ECHA-Klassifizierungen und PubMed-Studien.
- Was sind schwangerschaftssichere Alternativen zu crataegus pinnatifida fruit extract?
- Siehe unsere kuratierte Liste der schwangerschaftssicheren Alternativen zu crataegus pinnatifida fruit extract basierend auf ähnlicher Funktion.
Prüfe jede Zutatenliste in 2 Sekunden
Lade VeriMom kostenlos — scanne jedes Produkt und sieh sofort die Schwangerschafts-Sicherheitsbewertung.
Medizinischer Haftungsausschluss
Diese Informationen dienen ausschließlich Bildungszwecken und stellen keine medizinische Beratung dar. Sicherheitsbewertungen basieren auf öffentlich zugänglichen Daten und spiegeln möglicherweise nicht alle Risiken wider. Konsultieren Sie immer Ihren Arzt, bevor Sie ein Produkt während der Schwangerschaft oder Stillzeit verwenden.